156 related articles for article (PubMed ID: 8063611)
21. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas.
Lauwers GY; Scott GV; Karpeh MS
Cancer; 1995 May; 75(9):2209-13. PubMed ID: 7712429
[TBL] [Abstract][Full Text] [Related]
22. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
23. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
[TBL] [Abstract][Full Text] [Related]
24. Studies on microsatellite instability in p16 gene and expression of hMSH2 mRNA in human gastric cancer tissues.
Zhang QX; Ding Y; Le XP; Du P
World J Gastroenterol; 2003 Mar; 9(3):437-41. PubMed ID: 12632492
[TBL] [Abstract][Full Text] [Related]
25. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
26. [A study of loss of heterozygosity and mRNA expression at DCC locus in gastric cancers].
Wang D; Fang D; Luo Y
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):331-4. PubMed ID: 9387268
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.
Nishizuka S; Tamura G; Terashima M; Satodate R
J Pathol; 1998 May; 185(1):38-43. PubMed ID: 9713358
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of c-met mRNA in human gastric carcinomas.
Kuniyasu H; Yasui W; Yokozaki H; Kitadai Y; Tahara E
Int J Cancer; 1993 Aug; 55(1):72-5. PubMed ID: 8344755
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of gastric cancer.
Tahara E
World J Surg; 1995; 19(4):484-8; discussion 489-90. PubMed ID: 7676688
[TBL] [Abstract][Full Text] [Related]
32. Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Nov; 115(11):1274-80. PubMed ID: 18092960
[TBL] [Abstract][Full Text] [Related]
33. Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa.
Xiang YY; Wang DY; Tanaka M; Suzuki M; Kiyokawa E; Igarashi H; Naito Y; Shen Q; Sugimura H
Int J Cancer; 1997 Feb; 74(1):1-6. PubMed ID: 9036861
[TBL] [Abstract][Full Text] [Related]
34. Allelotype of adenoma and differentiated adenocarcinoma of the stomach.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Terashima M; Eda Y; Satodate R
J Pathol; 1996 Dec; 180(4):371-7. PubMed ID: 9014856
[TBL] [Abstract][Full Text] [Related]
35. Expression of multidrug resistance gene (mdr-1) mRNA in gastric and colorectal cancers.
Motoo Y; Su SB; Nakatani MT; Sawabu N
Anticancer Res; 1998; 18(3B):1903-6. PubMed ID: 9677442
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite instability in double primary cancers of the colorectum and stomach.
Kim HS; Cho NB; Yoo JH; Shin KH; Park JG; Kim YI; Kim WH
Mod Pathol; 2001 Jun; 14(6):543-8. PubMed ID: 11406654
[TBL] [Abstract][Full Text] [Related]
37. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
38. Over-expression of bcl-xL gene in human gastric adenomas and carcinomas.
Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Miyagawa JI; Minami T; Kiyohara T; Zushi S; Kitamura S; Isozaki K; Matsuzawa Y
Int J Cancer; 1996 Dec; 68(6):727-30. PubMed ID: 8980174
[TBL] [Abstract][Full Text] [Related]
39. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
[TBL] [Abstract][Full Text] [Related]
40. Methylation of CpG sites in exon 2 of the bcl-2 gene occurs in colorectal carcinoma.
Babidge WJ; Butler LM; Burton MA; Cowled PA
Anticancer Res; 2001; 21(4A):2809-14. PubMed ID: 11724359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
